These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pituitary transcription factors: from congenital deficiencies to gene therapy. Quentien MH; Barlier A; Franc JL; Pellegrini I; Brue T; Enjalbert A J Neuroendocrinol; 2006 Sep; 18(9):633-42. PubMed ID: 16879162 [TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Rainbow LA; Rees SA; Shaikh MG; Shaw NJ; Cole T; Barrett TG; Kirk JM Clin Endocrinol (Oxf); 2005 Feb; 62(2):163-8. PubMed ID: 15670191 [TBL] [Abstract][Full Text] [Related]
8. Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. Reynaud R; Gueydan M; Saveanu A; Vallette-Kasic S; Enjalbert A; Brue T; Barlier A J Clin Endocrinol Metab; 2006 Sep; 91(9):3329-36. PubMed ID: 16735499 [TBL] [Abstract][Full Text] [Related]
10. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Turton JP; Mehta A; Raza J; Woods KS; Tiulpakov A; Cassar J; Chong K; Thomas PQ; Eunice M; Ammini AC; Bouloux PM; Starzyk J; Hindmarsh PC; Dattani MT Clin Endocrinol (Oxf); 2005 Jul; 63(1):10-8. PubMed ID: 15963055 [TBL] [Abstract][Full Text] [Related]
11. PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. de Graaff LC; Argente J; Veenma DC; Drent ML; Uitterlinden AG; Hokken-Koelega AC Horm Res Paediatr; 2010; 73(5):363-71. PubMed ID: 20389107 [TBL] [Abstract][Full Text] [Related]
12. Growth hormone deficiency and combined pituitary hormone deficiency: does the genotype matter? Dattani MT Clin Endocrinol (Oxf); 2005 Aug; 63(2):121-30. PubMed ID: 16060904 [TBL] [Abstract][Full Text] [Related]
13. Basic science and clinical research advances in the pituitary transcription factors: Pit-1 and Prop-1. Kerr J; Wood W; Ridgway EC Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):359-63. PubMed ID: 18594277 [TBL] [Abstract][Full Text] [Related]
14. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. Vallette-Kasic S; Barlier A; Teinturier C; Diaz A; Manavela M; Berthezène F; Bouchard P; Chaussain JL; Brauner R; Pellegrini-Bouiller I; Jaquet P; Enjalbert A; Brue T J Clin Endocrinol Metab; 2001 Sep; 86(9):4529-35. PubMed ID: 11549703 [TBL] [Abstract][Full Text] [Related]
15. Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Pfäffle R; Klammt J Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):43-60. PubMed ID: 21396574 [TBL] [Abstract][Full Text] [Related]
16. Auxological and endocrine phenotype in a population-based cohort of patients with PROP1 gene defects. Lebl J; Vosáhlo J; Pfaeffle RW; Stobbe H; Cerná J; Novotná D; Zapletalová J; Kalvachová B; Hána V; Weiss V; Blum WF Eur J Endocrinol; 2005 Sep; 153(3):389-96. PubMed ID: 16131601 [TBL] [Abstract][Full Text] [Related]
17. The de novo Q167K mutation in the POU1F1 gene leads to combined pituitary hormone deficiency in an Italian patient. Malvagia S; Poggi GM; Pasquini E; Donati MA; Pela I; Morrone A; Zammarchi E Pediatr Res; 2003 Nov; 54(5):635-40. PubMed ID: 12904605 [TBL] [Abstract][Full Text] [Related]